drugset / Trial / NCT00854061

Study of T-PRED(TM) Compared to Pred Forte(R) II

NCT00854061

Phase 3 Completed 172 enrolled Bausch & Lomb Incorporated
RandomizedCrossoverQuadruple-blindBasic science

Summary

Study of T-PRED(TM) Compared to Pred Forte(R)

Timeline

Start
2009-02
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified Topical
Subject Tobramycin Small molecule Topical

Indications